Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
ObjectiveTo evaluate the effect of pressing needle therapy on depression, anxiety, and sleep in patients recovering from COVID-19, and to provide a more effective and convenient treatment for the sequelae of COVID-19.MethodsA total of 136 patients recovering from COVID-19 were randomized into a treatment group (68 cases) and a control group (68 cases, with one case dropping out). The treatment group received pressing needle therapy, while the control group received sham pressing needle therapy, three times a week for 4 weeks. The Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and Insomnia Severity Index (ISI) were used to evaluate patients’ emotional states and sleep quality. These scales were assessed before, after, and at a 1-month follow-up.ResultsCompared to before treatment, the treatment group showed a significant decrease in PHQ-9 scores (p < 0.05, Cohen’s d = 1.26), GAD-7 scores (p < 0.05, Cohen’s d = 1.10), and ISI scores (p < 0.05, Cohen’s d = 0.94) after treatment. Similarly, at the 1-month follow-up, significant decreases were observed in PHQ-9 scores (p < 0.05, Cohen’s d = 1.11), GAD-7 scores (p < 0.05, Cohen’s d = 0.88), and ISI scores (p < 0.05, Cohen’s d = 0.94). In contrast, the control group demonstrated no statistically significant differences in PHQ-9, GAD-7, or ISI scores after treatment or at the 1-month follow-up (p > 0.05). Between the two groups, statistically significant improvements (p < 0.05) were observed in PHQ-9 scores (Cohen’s d = 1.47), GAD-7 scores (Cohen’s d = 1.61), and ISI scores (Cohen’s d = 1.06) after treatment. At the 1-month follow-up, statistically significant differences (p < 0.05) between the two groups were also noted in PHQ-9 scores (Cohen’s d = 1.10), GAD-7 scores (Cohen’s d = 0.87), and ISI scores (Cohen’s d = 0.92).ConclusionPressing needle therapy significantly improves the mental health and sleep quality of patients recovering from COVID-19. It enhances their quality of life, promotes early recovery, and is simple and easy to administer, making it a treatment worthy of clinical application.Clinical trial registrationhttps://www.chictr.org.cn/.
ObjectiveTo evaluate the effect of pressing needle therapy on depression, anxiety, and sleep in patients recovering from COVID-19, and to provide a more effective and convenient treatment for the sequelae of COVID-19.MethodsA total of 136 patients recovering from COVID-19 were randomized into a treatment group (68 cases) and a control group (68 cases, with one case dropping out). The treatment group received pressing needle therapy, while the control group received sham pressing needle therapy, three times a week for 4 weeks. The Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and Insomnia Severity Index (ISI) were used to evaluate patients’ emotional states and sleep quality. These scales were assessed before, after, and at a 1-month follow-up.ResultsCompared to before treatment, the treatment group showed a significant decrease in PHQ-9 scores (p < 0.05, Cohen’s d = 1.26), GAD-7 scores (p < 0.05, Cohen’s d = 1.10), and ISI scores (p < 0.05, Cohen’s d = 0.94) after treatment. Similarly, at the 1-month follow-up, significant decreases were observed in PHQ-9 scores (p < 0.05, Cohen’s d = 1.11), GAD-7 scores (p < 0.05, Cohen’s d = 0.88), and ISI scores (p < 0.05, Cohen’s d = 0.94). In contrast, the control group demonstrated no statistically significant differences in PHQ-9, GAD-7, or ISI scores after treatment or at the 1-month follow-up (p > 0.05). Between the two groups, statistically significant improvements (p < 0.05) were observed in PHQ-9 scores (Cohen’s d = 1.47), GAD-7 scores (Cohen’s d = 1.61), and ISI scores (Cohen’s d = 1.06) after treatment. At the 1-month follow-up, statistically significant differences (p < 0.05) between the two groups were also noted in PHQ-9 scores (Cohen’s d = 1.10), GAD-7 scores (Cohen’s d = 0.87), and ISI scores (Cohen’s d = 0.92).ConclusionPressing needle therapy significantly improves the mental health and sleep quality of patients recovering from COVID-19. It enhances their quality of life, promotes early recovery, and is simple and easy to administer, making it a treatment worthy of clinical application.Clinical trial registrationhttps://www.chictr.org.cn/.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.